Bruker says German court rules against 10x Genomics patent claim

Bruker (BRKR) announced that the German Federal Patent Court has ruled in favor of NanoString Technologies Germany by invalidating European Patent No. 2794928B1 in Germany. NanoString is now a Bruker business following Bruker’s asset acquisition of the businesses of NanoString Technologies on May 6. The ‘928 Patent has been asserted by 10x Genomics (TXG) against NanoString in patent infringement cases in Germany and before the European Unified Patent Court involving NanoString’s CosMx Spatial Molecular Imager products for RNA detection. The Federal Patent Court ruled that the German part of the ‘928 Patent is invalid. NanoString “will promptly ask the German Higher Regional Court of Munich to permanently lift the injunction impacting NanoString’s CosMx products and the scientists who rely on them in Germany,” the company added.